US Stock MarketDetailed Quotes

ADXN Addex Therapeutics

Watchlist
  • 9.4500
  • +0.1197+1.28%
Close May 14 16:00 ET
10.10MMarket Cap-509P/E (TTM)

Addex Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
13.39%1.61M
-74.10%153.45K
-19.95%327.73K
244.08%630.88K
111.14%500.89K
-51.22%1.42M
49.04%592.43K
-39.97%409.42K
-81.53%183.35K
-71.90%237.24K
Operating revenue
13.39%1.61M
-74.10%153.45K
-19.95%327.73K
244.08%630.88K
111.14%500.89K
-51.22%1.42M
49.04%592.43K
-39.97%409.42K
-81.53%183.35K
-71.90%237.24K
Cost of revenue
Gross profit
Operating expense
-45.79%11.89M
-30.67%2.84M
-34.88%2.98M
-56.32%3.18M
-51.66%2.9M
19.11%21.94M
-12.47%4.09M
7.48%4.58M
32.30%7.28M
50.29%6M
Selling and administrative expenses
-28.78%7.2M
-33.86%1.7M
-26.78%1.75M
-7.24%1.95M
-40.90%1.8M
30.59%10.12M
44.05%2.58M
16.38%2.39M
13.82%2.1M
130.51%3.05M
-General and administrative expense
-28.78%7.2M
-33.86%1.7M
-26.78%1.75M
-7.24%1.95M
-40.90%1.8M
30.59%10.12M
44.05%2.58M
16.38%2.39M
13.82%2.1M
130.51%3.05M
Research and development costs
-72.60%2.75M
-58.98%454.31K
-52.04%833.48K
-83.93%751.86K
-71.73%708.78K
11.27%10.03M
-55.11%1.11M
-3.75%1.74M
25.34%4.68M
-8.76%2.51M
Depreciation amortization depletion
-5.32%305.95K
4.94%79.39K
-2.51%75.38K
-9.53%75.41K
-12.73%75.78K
-7.04%323.14K
-8.82%75.65K
-11.88%77.32K
--83.35K
--86.83K
-Depreciation and amortization
-5.32%305.95K
4.94%79.39K
-2.51%75.38K
-9.53%75.41K
-12.73%75.78K
-7.04%323.14K
-8.82%75.65K
-11.88%77.32K
--83.35K
--86.83K
Other operating expenses
10.99%1.64M
80.55%598.69K
-13.38%321.48K
-2.99%400.62K
-12.09%314.35K
12.10%1.47M
-0.91%331.59K
19.42%371.12K
620.89%412.99K
557.28%357.59K
Operating profit
49.89%-10.28M
23.31%-2.68M
36.34%-2.65M
64.09%-2.55M
58.36%-2.4M
-32.33%-20.52M
18.18%-3.5M
-16.53%-4.17M
-57.37%-7.09M
-83.05%-5.76M
Net non-operating interest income expense
315.60%42.36K
-72.84%4.78K
465.42%10.16K
178.50%9.52K
180.23%17.91K
65.95%-19.65K
304.66%17.58K
68.24%-2.78K
42.85%-12.13K
-104.39%-22.32K
Non-operating interest income
118.67%63.96K
-48.20%13.13K
278.86%13.66K
6,443.63%13.35K
24,980.00%23.83K
449.62%29.25K
3,261.67%25.35K
190.96%3.61K
-88.12%204
-99.98%95
Non-operating interest expense
-55.81%21.61K
7.58%8.36K
-45.13%3.5K
-68.96%3.83K
-73.59%5.92K
-22.40%48.9K
-16.88%7.77K
-36.09%6.38K
-46.24%12.33K
8.07%22.41K
Other net income (expense)
-20.02%-317.29K
-4.96%-179.2K
-59.14%25.38K
-17.95%-137.9K
34.15%-25.57K
-224.88%-264.36K
-22.00%-170.74K
556.33%62.12K
27.96%-116.91K
-38.83K
Gain on sale of security
-20.02%-317.29K
-4.96%-179.2K
-59.14%25.38K
-17.95%-137.9K
34.15%-25.57K
-224.88%-264.36K
-22.00%-170.74K
556.33%62.12K
27.96%-116.91K
---38.83K
Income before tax
49.26%-10.56M
21.76%-2.86M
36.29%-2.62M
62.95%-2.68M
58.67%-2.41M
-35.52%-20.8M
17.46%-3.65M
-14.16%-4.11M
-53.97%-7.22M
-120.63%-5.82M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
49.26%-10.56M
21.76%-2.86M
36.29%-2.62M
62.95%-2.68M
58.67%-2.41M
-35.52%-20.8M
17.46%-3.65M
-14.16%-4.11M
-53.97%-7.22M
-120.63%-5.82M
Net income continuous Operations
49.26%-10.56M
21.76%-2.86M
36.29%-2.62M
62.95%-2.68M
58.67%-2.41M
-35.52%-20.8M
17.46%-3.65M
-14.16%-4.11M
-53.97%-7.22M
-120.63%-5.82M
Minority interest income
Net income attributable to the parent company
49.26%-10.56M
21.76%-2.86M
36.29%-2.62M
62.95%-2.68M
58.67%-2.41M
-35.52%-20.8M
17.46%-3.65M
-14.16%-4.11M
-53.97%-7.22M
-120.63%-5.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.26%-10.56M
21.76%-2.86M
36.29%-2.62M
62.95%-2.68M
58.67%-2.41M
-35.52%-20.8M
17.46%-3.65M
-14.16%-4.11M
-53.97%-7.22M
-120.63%-5.82M
Basic earnings per share
69.57%-16.8
25.00%-3.6
66.67%-3.6
78.95%-4.8
73.33%-4.8
-2.22%-55.2
69.23%-4.8
18.18%-10.8
-35.71%-22.8
-87.50%-18
Diluted earnings per share
69.57%-16.8
25.00%-3.6
66.67%-3.6
78.95%-4.8
73.33%-4.8
-2.22%-55.2
69.23%-4.8
18.18%-10.8
-35.71%-22.8
-87.50%-18
Dividend per share
Currency Unit
CHF
CHF
CHF
CHF
CHF
CHF
CHF
CHF
CHF
CHF
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 13.39%1.61M-74.10%153.45K-19.95%327.73K244.08%630.88K111.14%500.89K-51.22%1.42M49.04%592.43K-39.97%409.42K-81.53%183.35K-71.90%237.24K
Operating revenue 13.39%1.61M-74.10%153.45K-19.95%327.73K244.08%630.88K111.14%500.89K-51.22%1.42M49.04%592.43K-39.97%409.42K-81.53%183.35K-71.90%237.24K
Cost of revenue
Gross profit
Operating expense -45.79%11.89M-30.67%2.84M-34.88%2.98M-56.32%3.18M-51.66%2.9M19.11%21.94M-12.47%4.09M7.48%4.58M32.30%7.28M50.29%6M
Selling and administrative expenses -28.78%7.2M-33.86%1.7M-26.78%1.75M-7.24%1.95M-40.90%1.8M30.59%10.12M44.05%2.58M16.38%2.39M13.82%2.1M130.51%3.05M
-General and administrative expense -28.78%7.2M-33.86%1.7M-26.78%1.75M-7.24%1.95M-40.90%1.8M30.59%10.12M44.05%2.58M16.38%2.39M13.82%2.1M130.51%3.05M
Research and development costs -72.60%2.75M-58.98%454.31K-52.04%833.48K-83.93%751.86K-71.73%708.78K11.27%10.03M-55.11%1.11M-3.75%1.74M25.34%4.68M-8.76%2.51M
Depreciation amortization depletion -5.32%305.95K4.94%79.39K-2.51%75.38K-9.53%75.41K-12.73%75.78K-7.04%323.14K-8.82%75.65K-11.88%77.32K--83.35K--86.83K
-Depreciation and amortization -5.32%305.95K4.94%79.39K-2.51%75.38K-9.53%75.41K-12.73%75.78K-7.04%323.14K-8.82%75.65K-11.88%77.32K--83.35K--86.83K
Other operating expenses 10.99%1.64M80.55%598.69K-13.38%321.48K-2.99%400.62K-12.09%314.35K12.10%1.47M-0.91%331.59K19.42%371.12K620.89%412.99K557.28%357.59K
Operating profit 49.89%-10.28M23.31%-2.68M36.34%-2.65M64.09%-2.55M58.36%-2.4M-32.33%-20.52M18.18%-3.5M-16.53%-4.17M-57.37%-7.09M-83.05%-5.76M
Net non-operating interest income expense 315.60%42.36K-72.84%4.78K465.42%10.16K178.50%9.52K180.23%17.91K65.95%-19.65K304.66%17.58K68.24%-2.78K42.85%-12.13K-104.39%-22.32K
Non-operating interest income 118.67%63.96K-48.20%13.13K278.86%13.66K6,443.63%13.35K24,980.00%23.83K449.62%29.25K3,261.67%25.35K190.96%3.61K-88.12%204-99.98%95
Non-operating interest expense -55.81%21.61K7.58%8.36K-45.13%3.5K-68.96%3.83K-73.59%5.92K-22.40%48.9K-16.88%7.77K-36.09%6.38K-46.24%12.33K8.07%22.41K
Other net income (expense) -20.02%-317.29K-4.96%-179.2K-59.14%25.38K-17.95%-137.9K34.15%-25.57K-224.88%-264.36K-22.00%-170.74K556.33%62.12K27.96%-116.91K-38.83K
Gain on sale of security -20.02%-317.29K-4.96%-179.2K-59.14%25.38K-17.95%-137.9K34.15%-25.57K-224.88%-264.36K-22.00%-170.74K556.33%62.12K27.96%-116.91K---38.83K
Income before tax 49.26%-10.56M21.76%-2.86M36.29%-2.62M62.95%-2.68M58.67%-2.41M-35.52%-20.8M17.46%-3.65M-14.16%-4.11M-53.97%-7.22M-120.63%-5.82M
Income tax 0000000000
Net income 49.26%-10.56M21.76%-2.86M36.29%-2.62M62.95%-2.68M58.67%-2.41M-35.52%-20.8M17.46%-3.65M-14.16%-4.11M-53.97%-7.22M-120.63%-5.82M
Net income continuous Operations 49.26%-10.56M21.76%-2.86M36.29%-2.62M62.95%-2.68M58.67%-2.41M-35.52%-20.8M17.46%-3.65M-14.16%-4.11M-53.97%-7.22M-120.63%-5.82M
Minority interest income
Net income attributable to the parent company 49.26%-10.56M21.76%-2.86M36.29%-2.62M62.95%-2.68M58.67%-2.41M-35.52%-20.8M17.46%-3.65M-14.16%-4.11M-53.97%-7.22M-120.63%-5.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.26%-10.56M21.76%-2.86M36.29%-2.62M62.95%-2.68M58.67%-2.41M-35.52%-20.8M17.46%-3.65M-14.16%-4.11M-53.97%-7.22M-120.63%-5.82M
Basic earnings per share 69.57%-16.825.00%-3.666.67%-3.678.95%-4.873.33%-4.8-2.22%-55.269.23%-4.818.18%-10.8-35.71%-22.8-87.50%-18
Diluted earnings per share 69.57%-16.825.00%-3.666.67%-3.678.95%-4.873.33%-4.8-2.22%-55.269.23%-4.818.18%-10.8-35.71%-22.8-87.50%-18
Dividend per share
Currency Unit CHFCHFCHFCHFCHFCHFCHFCHFCHFCHF
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg